A CDC advisory panel voted unanimously on Sunday to recommend Johnson & Johnson’s COVID-19 shot for widespread use, and U.S. officials said initial shipments would start on Sunday. Providing a final clearance for the vaccine a day after it was authorized by U.S. regulators, the Advisory Committee on Immunization Practices (ACIP) voted 12-0 to recommend the vaccine from J&J as appropriate for Americans 18 and older.. … “We’re getting these doses out the door as soon as they’re available to ensure vaccines get into arms as quickly as possible,” one senior U.S. official told reporters late on Sunday, adding that initial deliveries were expected by Tuesday.